Sérgio Rizzo

3.0k total citations
74 papers, 2.0k citations indexed

About

Sérgio Rizzo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sérgio Rizzo has authored 74 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Sérgio Rizzo's work include Lung Cancer Treatments and Mutations (17 papers), Colorectal Cancer Treatments and Studies (13 papers) and Lung Cancer Research Studies (10 papers). Sérgio Rizzo is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Colorectal Cancer Treatments and Studies (13 papers) and Lung Cancer Research Studies (10 papers). Sérgio Rizzo collaborates with scholars based in Italy, United States and Argentina. Sérgio Rizzo's co-authors include Antonio Russo, Viviana Bazan, Antonio Galvano, Giuseppe Bronte, Daniele Santini, Francesco Passiglia, Angela Listì, Marta Castiglia, Giuseppe Cicero and Lorena Incorvaia and has published in prestigious journals such as Cancer, Scientific Reports and Annals of the New York Academy of Sciences.

In The Last Decade

Sérgio Rizzo

71 papers receiving 1.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Sérgio Rizzo 1.0k 635 559 402 230 74 2.0k
Debashis Sarker 1.1k 1.0× 505 0.8× 1.1k 1.9× 448 1.1× 174 0.8× 132 2.3k
Stephen Welch 1.0k 1.0× 388 0.6× 626 1.1× 279 0.7× 96 0.4× 124 1.9k
Yan Ning 1.3k 1.3× 313 0.5× 959 1.7× 548 1.4× 441 1.9× 105 2.4k
David Jamieson 731 0.7× 383 0.6× 502 0.9× 217 0.5× 161 0.7× 42 1.5k
Agustin A. García 1.5k 1.5× 681 1.1× 1.1k 1.9× 392 1.0× 194 0.8× 114 3.1k
Christian M. Kurbacher 1.1k 1.1× 347 0.5× 724 1.3× 430 1.1× 295 1.3× 92 2.3k
Xichun Hu 1.3k 1.3× 770 1.2× 1.2k 2.1× 715 1.8× 150 0.7× 155 2.8k
Susan Ellard 968 0.9× 964 1.5× 823 1.5× 526 1.3× 136 0.6× 81 2.4k
Ioannis A. Voutsadakis 1.2k 1.2× 474 0.7× 914 1.6× 639 1.6× 187 0.8× 161 2.3k
Michael B. Jameson 780 0.8× 309 0.5× 737 1.3× 450 1.1× 344 1.5× 104 2.0k

Countries citing papers authored by Sérgio Rizzo

Since Specialization
Citations

This map shows the geographic impact of Sérgio Rizzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sérgio Rizzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sérgio Rizzo more than expected).

Fields of papers citing papers by Sérgio Rizzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sérgio Rizzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sérgio Rizzo. The network helps show where Sérgio Rizzo may publish in the future.

Co-authorship network of co-authors of Sérgio Rizzo

This figure shows the co-authorship network connecting the top 25 collaborators of Sérgio Rizzo. A scholar is included among the top collaborators of Sérgio Rizzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sérgio Rizzo. Sérgio Rizzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rizzo, Sérgio, et al.. (2025). Safety profiles of the new target therapies—pemigatinib, futibatinib, and ivosidenib—for the treatment of cholangiocarcinoma: a systematic review. Therapeutic Advances in Drug Safety. 16. 1601799600–1601799600.
2.
3.
Piazza, L, et al.. (2024). Cardiotoxicity associated with immune checkpoint inhibitors: Systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 206. 104587–104587. 8 indexed citations
4.
Descalzo, A.M., Andrea Biolatto, Sérgio Rizzo, et al.. (2021). Oxidative stability parameters and sensory properties of in-shell "Stuart" pecans [Carya illinoinensis (Wangenh.) K.Koch] stored at different temperatures under non-accelerated conditions. Postharvest Biology and Technology. 179. 111591–111591. 9 indexed citations
5.
Gambino, Caterina Maria, Giulia Accardi, Anna Aiello, et al.. (2020). Uncoupling Protein 2 as genetic risk factor for systemic lupus erythematosus: association with malondialdehyde levels and intima media thickness. PubMed. 68(6). 609–618. 3 indexed citations
6.
Galvano, Antonio, Lorena Incorvaia, Giuseppe Badalamenti, et al.. (2019). How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis. Cancers. 11(8). 1189–1189. 3 indexed citations
7.
Descalzo, A.M., Sérgio Rizzo, Adrien Servent, et al.. (2018). Oxidative status of a yogurt-like fermented maize product containing phytosterols. Journal of Food Science and Technology. 55(5). 1859–1869. 12 indexed citations
8.
Passiglia, Francesco, Sérgio Rizzo, Massimo Di Maïo, et al.. (2018). Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis. Scientific Reports. 8(1). 17270–17270. 6 indexed citations
9.
Passiglia, Francesco, Sérgio Rizzo, Massimo Di Maïo, et al.. (2018). The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis. Scientific Reports. 8(1). 13379–13379. 69 indexed citations
10.
11.
Basanta, María F., Sérgio Rizzo, Natalia Szerman, et al.. (2017). Plum (Prunus salicina) peel and pulp microparticles as natural antioxidant additives in breast chicken patties. Food Research International. 106. 1086–1094. 39 indexed citations
12.
Bronte, Giuseppe, Enrico Bronte, Giuseppina Novo, et al.. (2014). Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy. Expert Opinion on Drug Safety. 14(2). 253–267. 31 indexed citations
13.
Bronte, Giuseppe, Francesco Passiglia, Sérgio Rizzo, et al.. (2014). Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario. Expert Opinion on Biological Therapy. 15(1). 45–59. 8 indexed citations
14.
Rizzo, Sérgio, et al.. (2011). Vandali : l'assalto alle bellezze d'Italia. Rizzoli eBooks. 1 indexed citations
15.
Rizzo, Sérgio, Giuseppe Bronte, Daniele Fanale, et al.. (2010). Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?. Cancer Treatment Reviews. 36. S56–S61. 75 indexed citations
16.
Russo, Antonio, Sérgio Rizzo, Fabio Fulfaro, et al.. (2009). Gemcitabine‐based doublets versus single‐agent therapy for elderly patients with advanced nonsmall cell lung cancer. Cancer. 115(9). 1924–1931. 19 indexed citations
17.
Russo, Antonio, et al.. (2008). Hereditary ovarian cancer. Critical Reviews in Oncology/Hematology. 69(1). 28–44. 85 indexed citations
18.
Russo, Antonio, Valentina Calò, Valentina Agnese, et al.. (2008). Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?. Breast Cancer Research and Treatment. 113(1). 67–70. 21 indexed citations
19.
Mufunda, J, Peter Nyarangó, Abdulmumini Usman, et al.. (2007). Prevalence of tobacco use in Eritrea: Results from a noncommunicable disease risk factor survey. Nicotine & Tobacco Research. 9(7). 777–779. 4 indexed citations
20.
Carruba, Giuseppe, Letizia Cocciadiferro, Vincenzo Bellavia, et al.. (2004). Intercellular Communication and Human Hepatocellular Carcinoma. Annals of the New York Academy of Sciences. 1028(1). 202–212. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Debashis Sarker Breakdown of academic impact, for papers by Stephen Welch Breakdown of academic impact, for papers by Yan Ning Breakdown of academic impact, for papers by David Jamieson Breakdown of academic impact, for papers by Agustin A. García Breakdown of academic impact, for papers by Christian M. Kurbacher Breakdown of academic impact, for papers by Xichun Hu Breakdown of academic impact, for papers by Susan Ellard Breakdown of academic impact, for papers by Ioannis A. Voutsadakis Breakdown of academic impact, for papers by Michael B. Jameson
Rankless by CCL
2026